Cargando…
Telomeres and COVID‐19
The medical, public health, and scientific communities are grappling with monumental imperatives to contain COVID‐19, develop effective vaccines, identify efficacious treatments for the infection and its complications, and find biomarkers that detect patients at risk of severe disease. The focus of...
Autor principal: | Aviv, Abraham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276714/ https://www.ncbi.nlm.nih.gov/pubmed/32427393 http://dx.doi.org/10.1096/fj.202001025 |
Ejemplares similares
-
Is lymphopenia different between SARS and COVID‐19 patients?
por: Yan, Shaomin, et al.
Publicado: (2021) -
S100A8 may govern hyper‐inflammation in severe COVID‐19
por: Deguchi, Atsuko, et al.
Publicado: (2021) -
COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
por: Sorokin, Alexander V., et al.
Publicado: (2020) -
Sialylation of host proteins as targetable risk factor for COVID‐19 susceptibility and spreading: A hypothesis
por: Bongiovanni, Antonella, et al.
Publicado: (2021) -
Will shrinking body size and increasing species diversity of crustaceans follow the warming of the Arctic littoral?
por: Węsławski, Jan M., et al.
Publicado: (2020)